sublingual glp-1 Is a Around the Corner? Here's What's Real (and What's Hype) Sublingual GLP-1/GIP (Tirz) Oral Drops
Description
GLP-1based therapies are powerful
Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide
Mol Metab 49, 101181 (2021)
Market Challenges High Cost of GLP-1 Agonists:The financial burden associated with GLP-1 agonists remains a significant challenge, with average monthly treatment costsexceeding USD 1,000
Prices will rise to $199 a month for certain doses after April 15, 2026
Nausea, vomiting, diarrhea, and reduced appetite typically occur during dose escalation
